United States · FDA National Drug Code directory
Lithium Carbonate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 46708-304_f4a09dd5-000a-48d2-9681-d5bc360164f1
- Product NDC
- 46708-304
- Form
- CAPSULE
- Composition / generic term
- Lithium Carbonate
- Labeler
- Alembic Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20161227
- Source listing expiry
- 20261231
Source-listed ingredients
- LITHIUM CARBONATE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (46708-304-30) · 46708-304-30
- 100 CAPSULE in 1 BOTTLE (46708-304-31) · 46708-304-31
- 500 CAPSULE in 1 BOTTLE (46708-304-71) · 46708-304-71
- 1000 CAPSULE in 1 BOTTLE (46708-304-91) · 46708-304-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →